表紙:世界のユービオティクス市場:2021~2028年
市場調査レポート
商品コード
1021251

世界のユービオティクス市場:2021~2028年

Global Eubiotics Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
世界のユービオティクス市場:2021~2028年
出版日: 2021年07月30日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ユーバイオティクスとは、免疫システムを向上させるための天然の刺激剤です。主に動物の飼料に抗生物質の代替として使用されます。これらの飼料添加物は、動物の消化器系の健康をサポートすることが証明されています。養鶏、畜産、養豚、養殖などの動物飼育の分野では、ユーバイオティクスの使用が注目されています。動物飼育における抗生物質の使用に対する規制が厳しくなったことが、世界のユービオティクス市場の成長につながりました。抗生物質の過剰使用による耐性菌の増加に伴い、いくつかの国では抗生物質の使用を制限したり、禁止したりしています。ユービオティクスは、消化器系の健康、免疫系の健康、体重増加、一般的な健康などの分野で効果が期待できる、最も効果的な成長促進剤として発展してきました。ユービオティクスは、水産養殖において、より高い生産量、より強い免疫力、より良い飼料要求率を得るのに役立ちます。これらの要因がユービオティクスの世界市場の成長を促進しています。世界のユービオティクスの市場規模は、今後拡大すると予測されます。

当レポートでは、世界のユービオティクス市場について調査し、市場の概要とともに、タイプ別、形態別、用途別、最終用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 世界のユービオティクス市場-範囲と調査手法

  • 調査手法
  • 市場の範囲

第2章 世界のユービオティクス市場-主要な動向と開発

第3章 世界のユービオティクス市場-エグゼクティブサマリー

  • タイプ別の市場内訳
  • 形態別の市場内訳
  • 用途別の市場内訳
  • 最終用途別の市場内訳

第4章 世界のユービオティクス市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析

第5章 世界のユービオティクス市場-業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析

第6章 世界のユービオティクス市場-COVID-19分析

  • ポーターのファイブフォース分析
    • COVID-19前の市場シナリオ
    • COVID-19現在の市場シナリオ
    • COVID-19後または将来のシナリオ
  • COVID-19における価格のダイナミクス
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ

第7章 世界のユービオティクス市場-タイプ別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%)、タイプ別セグメント
    • タイプ別市場魅力指数
  • プロバイオティクス
    • イントロダクション
    • 百万米ドル、2018~2028年、および前年比成長分析(%)、2020~2028年
  • プレバイオティクス
  • エッセンシャルオイル
  • 有機酸
  • 外因性酵素

第8章 世界のユービオティクス市場-形態別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%)、形態別
    • 形態別の市場魅力指数
  • ドライ
    • イントロダクション
    • 百万米ドル、2018~2028年、および前年比成長分析(%)、2020~2028年
  • 液体

第9章 世界のユービオティクス市場-用途別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 用途別の市場魅力指数
  • 消化器系の健康
    • イントロダクション
    • 百万米ドル、2018~2028年、および前年比成長分析(%)、2020~2028年
  • 免疫系
  • 飼料効率
  • その他

第10章 世界のユービオティクス市場-最終用途別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%)、最終用途別
    • 最終用途別の市場魅力指数
  • 家禽飼料
    • イントロダクション
    • 百万米ドル、2018~2028年、および前年比成長分析(%)、2020~2028年
  • 豚の餌
  • 家畜飼料
  • 水産飼料
  • その他

第11章 世界のユービオティクス市場-地域別

  • イントロダクション
    • 市場規模分析、および地域別の前年比成長分析(%)
    • 地域別の市場魅力指数
  • 北米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、タイプ別
    • 市場規模分析、および前年比成長分析(%)、形態別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、最終用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • 南米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、タイプ別
    • 市場規模分析、および前年比成長分析(%)、形態別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、最終用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • 欧州
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、タイプ別
    • 市場規模分析、および前年比成長分析(%)、形態別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、最終用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • アジア太平洋
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、タイプ別
    • 市場規模分析、および前年比成長分析(%)、形態別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、最終用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • 中東とアフリカ
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、タイプ別
    • 市場規模分析、および前年比成長分析(%)、形態別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、最終用途別

第12章 世界のユービオティクス市場-競合情勢環境

  • 競合シナリオ
  • 競合他社の戦略分析
  • 市場ポジショニング/シェア分析
  • 合併と買収の分析

第13章 企業プロファイル

  • Cargill, Incorporated
    • 企業概要
    • タイプポートフォリオと概要
    • 主なハイライト
    • 財務概要
  • BASF SE
  • DuPont de Numerous, Inc.
  • Chr. Hansen Holding A/S
  • Royal DSM
  • Novozymes A/S
  • Calpis Co., Ltd.
  • Lesaffre
  • Kemin Industries
  • Lallemand Inc.

第14章 世界のユービオティクス市場-重要考察

第15章 世界のユービオティクス市場-DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMFB3729

Market Overview:

Eubiotics are the natural stimulants that help in improving the immune system. They are primarily used as alternative to antibiotics in animal feed. These feed additives are proven to support digestive health in animals. The use of eubiotics is gaining prominence across poultry, livestock, swine and aquaculture among other animal growing activities. The stringent regulatory limitations on use of antibiotics in animal growing led to the growth of global eubiotics market. As over utilization of antibiotics increase resistant bacteria, several nations are commissioning restrictions and even imposing bans on use of antibiotics. Eubiotics evolved as the most effective growth promoters with potential benefits in areas such as digestive health, immune system health, weight gain and general health. Eubiotics help obtain higher yield, stronger immunity and better feed conversion ratio in aquaculture. These factors are promoting the growth of global eubiotics market. The global market of eubiotics valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX% during the forecast period (2021-2028).

Market Dynamics: Regulatory restrictions on use of antibiotics is the key driver of the eubiotics market

The stringent regulations on the usage of antibiotics, is driving the growth of eubiotics market. One of the major reasons for regulations on use of antibiotics is development of antimicrobial resistance in animals. The antimicrobial resistance can result in much more severe infections caused through mutation and can spread those infections to human as well. According to WHO, about 2 million people in the U.S. suffer from antibiotic resistant infections each year while death toll reaches nearly 23,000. In 2017, the World Health Organization launched guidelines for reducing some of the antibiotics in food-producing animals, including complete restriction of these antibiotics for growth promotion and disease prevention without diagnosis. Thus, with the increasing demand to reduce the use of AGPs, the use of eubiotics is becoming popular especially in the poultry production.

Moreover, the growing poultry and aqua industry are likely to propel the growth of the market. As the growing global meat consumption is putting pressure on the livestock industry, farmers are using various feed additives such as eubiotics to increase yield.

Market Segments: Probiotics are highly popular due to their efficiency in improvement of feed conversion

Probiotics is the biggest segment of eubiotics market. Probiotics are microorganisms that improve the balance of pathogenic to beneficial bacteria in the gut, which has a positive impact on the host. It is highly used in poultry, aqua, livestock and swine feed as they aid in the delivery of desired effects such as growth performance, weight gain, and feed conversion by improving feed efficiency. Lactobacillus is one of the most commonly used probiotics in layers to improve egg quality. It effectively absorbs calcium from the gut, resulting in a thicker egg shell and full egg nutrition. Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus rhamnosus are some of the common types of probiotics known, while Enterococcus faecium and spore-forming Bacillus are the most common probiotic microorganisms used for swine feed. At present, in Europe, more than 40 preparations make use of probiotics for animal nutrition. Moreover, probiotics may benefit animals with various health conditions. For instance, certain strains of probiotics showed the positive results in reducing inflammation and gastrointestinal diseases in livestock.

However, lack of essential oils availability in animal feed applications owing to factors such as high demand from other applications, such as medical and food and beverages, is restraining market growth. Essential oils tend to show antimicrobial activity, thus are able to convene health benefits on the host and modify the gut microflora. Companies have developed customized blends such as those of thymol and cinnamaldehyde for specific purposes including improved digestion and weight gain. Such trends are expected to benefit segment growth over the forecast period.

Geographical Penetration: Europe is the major shareholder of the global eubiotics market owing to the huge demand of meat in this region

Europe accounts for the largest shareholder because of the rising demand in processed meat which is supporting the expansion of the regional eubiotics market. Moreover, increasing consumer awareness of the end quality of animal-derived products in Europe, as well as increasing demand for high-quality meat products, are expected to drive up the demand for eubiotics. According to Alltech feed survey, the estimated feed production was 1.07 billion tons, in 2017. According to FAO, the increase in livestock population is estimated to reach 30,033 million by 2030 supporting the growth in global feed demand. Moreover, efforts taken by livestock producers to comply with the prevalent regulations and ban on usage of antibiotics are resulting in high product demand. The growth of the market for eubiotics in the region is characterized by the presence of strict laws and regulations discouraging the usage of antibiotics, which is expected to benefit the market for eubiotics. Strong awareness regarding the usage of eubiotics and their benefits, presence of market players, and strong demand from countries such as Germany, U.K., France, and Spain are factors driving the overall regional demand. Germany is among the top producers of poultry in Europe. Also, the country has a significant presence of industry participants of other livestock such as swine and cattle. In addition, the presence of regional as well as international market participants in U.K. is also benefitting market growth. The concerns raised by the political as well as the social fraternity regarding traces of antibiotics and awareness regarding the quality of meat in the country are also expected to aid regional growth over the forecast period.

Key players are focusing more on Asia Pacific and are trying to increase their regional footprint by opening offices, manufacturing facilities, and R&D centers. Furthermore, the rising population in the region and the increasing disposable income of the people are factors responsible for a rise in meat consumption in the region. Such trends are expected to benefit the market for eubiotics in the region over the forecast period. Furthermore, strong demand from countries such as India, China, and Japan are expected to contribute to the overall regional market growth.

Competitive Landscape:

Key players in the market are inclined towards high investments in R&D activities for the development of superior products having high efficacy and more enhanced products. The industry is also characterized by mergers and acquisitions and the opening of new facilities to better serve the regional market. For instance, a key player such as DSM has established dedicated animal nutrition centres in China to better serve the local needs and to increase the regional feed market. Favourable regulatory scenario and the shift in trend towards the usage of alternatives of antibiotics are bound to attract new market entrants. Strategies such as the opening regional offices, manufacturing facilities, and R&D centres are adopted by companies to increase their regional footprint. For R&D, companies work in collaboration with research and educational institutes across the globe to gain a competitive advantage. Products specific to the applications such as yield and gut health have been developed by key players. Companies are focusing on developing regions, such as the Asia Pacific, for increasing their market share. Cargill invested USD 146 million in a feed plant in India. It produces 120,000 metric tons of feed per month and feeds 75,000 cows per day. DSM announced in June 2019 that Balancius, a product developed in collaboration with Novozymes, is now available in the European Union region. Balancius improves gastrointestinal function, increasing feed efficiency and improving the long-term viability of broiler production.

COVID-19 Impact: Pandemic had a negative impact on global eubiotics market

The outbreak of covid-19 had a negative impact on the eubiotics market. As the pandemic had a negative effect on the production of poultry meat, global chicken meat production which decreased by 2% and global chicken meat trade, which decreased by 1%. While Dutch government imposing strict regulations made it harder for Netherlands's feed producers to supply or deliver the produce, resulted in decline in sales by volume. Moreover, the reduced consumption of fish and meat during this period resulted in animal feed especially in South-Asian countries like Indonesia, Thailand and Philippines, with drop in fish demand by 1-4%. However, in some countries there was panic buying of feed during the first half of the pandemic. For instance, French feed producers reported intensified purchases of ingredients for feed and similar trend was observed in Germany which led to 10% hike in the sales of feed during March.

Why Purchase the Report?

  • Understand the current market scenario and viability of global eubiotics market over the forecast period
  • Visualize the composition of the global eubiotics market in terms of type, form, end user and application to identify major players, growth potential, and market strategies
  • Identify the key regulations prevailing in the market and understand their impact on the market over the forecast period
  • Understand the key business factors such as market competition, product pricing, new product developments, and patent filings pertaining in the market

What we offer?

  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  • Excel data sheet with valuable data points of the global eubiotics market - Regional and Country level segmentation
  • Product mapping in excel for the key products of all major market players
  • Market Share Analysis covering business revenues ($) and revenue share (%) of key market players

Target Audience:

  • Feed Additive Suppliers
  • Animal Feed Manufacturers
  • Import and Export Companies
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals

Table of Contents

1. Global Eubiotics Market -Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Global Eubiotics Market -Key Trends and Developments

3. Global Eubiotics Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Form
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End Use

4. Global Eubiotics Market - Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Global Eubiotics Market - Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Supply chain analysis
  • 5.3. Pricing analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis

6. Global Eubiotics Market - COVID-19 Analysis

  • 6.1. Porter's five forces analysis
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. Global Eubiotics Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Type Segment
    • 7.1.2. Market attractiveness index, By Type Segment
  • 7.2. Probiotics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 And Y-O-Y Growth Analysis (%), 2020-2028
  • 7.3. Prebiotics
  • 7.4. Essential Oils
  • 7.5. Organic Acid
  • 7.6. Exogenous Enzymes

8. Global Eubiotics Market - By Form

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Form Segment
    • 8.1.2. Market attractiveness index, By Form Segment
  • 8.2. Dry*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 And Y-O-Y Growth Analysis (%), 2020-2028
  • 8.3. Liquid

9. Global Eubiotics Market - By Application

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
    • 9.1.2. Market attractiveness index, By Application Segment
  • 9.2. Digestive Health*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 And Y-O-Y Growth Analysis (%), 2020-2028
  • 9.3. Immune System
  • 9.4. Feed Efficiency
  • 9.5. Others

10. Global Eubiotics Market - By End Use

  • 10.1. Introduction
    • 10.1.1. Market size analysis, and y-o-y growth analysis (%), By End Use Segment
    • 10.1.2. Market attractiveness index, By End Use Segment
  • 10.2. Poultry Feed*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2019-2028 And Y-O-Y Growth Analysis (%), 2020-2028
  • 10.3. Swine Feed
  • 10.4. Livestock Feed
  • 10.5. Aquafeed
  • 10.6. Others

11. Global Eubiotics Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key region-specific dynamics
    • 11.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End Use
    • 11.2.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. South America
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End Use
    • 11.3.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.3.7.1. Brazil
      • 11.3.7.2. Argentina
      • 11.3.7.3. Rest of South America
  • 11.4. Europe
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End Use
    • 11.4.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.4.7.1. Germany
      • 11.4.7.2. U.K.
      • 11.4.7.3. France
      • 11.4.7.4. Italy
      • 11.4.7.5. Rest of Europe
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End Use
    • 11.5.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End Use

12. Global Eubiotics Market - Competitive Landscape

  • 12.1. Competitive scenario
  • 12.2. Competitor strategy analysis
  • 12.3. Market positioning/share analysis
  • 12.4. Mergers and acquisitions analysis

13. Company Profiles

  • 13.1. Cargill, Incorporated
    • 13.1.1. Company Overview
    • 13.1.2. Type Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. BASF SE
  • 13.3. DuPont de Numerous, Inc.
  • 13.4. Chr. Hansen Holding A/S
  • 13.5. Royal DSM
  • 13.6. Novozymes A/S
  • 13.7. Calpis Co., Ltd.
  • 13.8. Lesaffre
  • 13.9. Kemin Industries
  • 13.10. Lallemand Inc.

14. Global Eubiotics Market - Premium Insights

15. Global Eubiotics Market - DataM

  • 15.1. Appendix
  • 15.2. About us and services
  • 15.3. Contact us